Skip to main content
Clinical Trials/RBR-3pd52f
RBR-3pd52f
Not yet recruiting
未知

Chronic Effect of Resistance Exercise associated with Blood Flow Restriction on Neuromotor Performance in healthy women: clinical trial, randomized and blinded

Caio Alano de Almeida Lins0 sitesSeptember 28, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Shoulder pain
Sponsor
Caio Alano de Almeida Lins
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 28, 2020
End Date
July 30, 2022
Last Updated
2 years ago
Study Type
Intervention
Sex
Female

Investigators

Sponsor
Caio Alano de Almeida Lins

Eligibility Criteria

Inclusion Criteria

  • Women aged between 18 and 35 will be included and classified as irregularly active according to the International Physical Activity Questionnaires (IPAQ). The participant will be eligible for the study if she has a body mass index (BMI) between 18\.5 and 30kg / m²; not have previous experience with training of blood flow restriction; not having diabetes mellitus or high blood pressure; not be a smoker; not using vasoactive medications or nutritional supplements regularly; not having presented an upper limb injury in the last 6 months; not having any severe rheumatic, cardiovascular or severe inflammatory or pulmonary conditions that prevent the performance of the assessments and the exercise protocol; not having any psychiatric illness or malignant tumor and not having contracted Zika or Chikungunya in the last year; not having undergone regular physical training for upper limbs in the last six months.

Exclusion Criteria

  • Participants who wish to leave the study will be excluded; have disabling health conditions that make it impossible for them to continue; use analgesic and / or anti\-inflammatory resources that can interfere with any result; perform unusual or strenuous physical activities during the study period; consecutively miss sessions 29, or fail to meet at least 70% of the entire training program.

Outcomes

Primary Outcomes

Not specified

Similar Trials